Inactive Instrument

Calendar Oxford BioMedica plc London S.E.

Equities

GB0006648157_GB

GB0006648157

Chart calendar Oxford BioMedica plc

b14c2e98ca5e7739f91078253.uHB5nOKFWfk4-OMnp7RlGl3gHgxPKLelRXQ9XjHrxF4.yRYV3rH2Na9zytJD6eBRV26JcmQ5ff76JxJZNQexmxH2NkrIg8Yxjk2ZjA~160c81ec8c8f4e1b624ea9d8935f91f4

Upcoming events on Oxford BioMedica plc

2024-04-29 02:00 am Q4 2023 Earnings Release
2024-04-29 08:00 am Q4 2023 Earnings Call

Past events on Oxford BioMedica plc

2023-10-10 12:00 am Cell & Gene Meeting on the Mesa Conference
2023-09-20 08:00 am Q2 2023 Earnings Call
2023-09-20 02:00 am Q2 2023 Earnings Release
2023-06-28 Stifel European Healthcare Summit
2023-06-23 10:00 am Annual General Meeting
2023-05-17 03:00 pm ASGCT Meeting
2023-04-25 08:00 am Q4 2022 Earnings Call
2023-04-25 02:00 am Q4 2022 Earnings Release
2023-03-26 SVB Securities Foundations of Discovery, Drugs & Dx Conference
2023-03-15 JP Morgan Pan-European Small/Mid Cap CEO Conference
2023-01-11 07:30 pm JP Morgan Healthcare Conference
2022-09-15 08:00 am Interim 2022 Earnings Call
2022-09-15 02:00 am Interim 2022 Earnings Release
2022-05-27 10:00 am Annual General Meeting
2022-04-25 Chardan Virtual Genetic Medicines and Cell Therapy Manufacturing Summit
2022-04-20 08:00 am FY 2021 Earnings Call
2022-04-20 02:00 am FY 2021 Earnings Release
2022-03-08 08:00 am Shareholders Meeting
2022-01-28 09:00 am Business Update Call
2021-11-29 Evercore ISI HealthCONx Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million GBP
Released
Forecast
Spread
66,8
70,3
-5.02%
64,1
69,3
-7.6%
87,7
85,7
2.35%
143
156
-8.49%
140
130
7.41%

90,5

EBITDA
Million GBP
Released
Forecast
Spread
13,4
13,2
1.71%
-5,20
-3,28
-58.68%
7,30
3,05
139.45%
35,9
33,8
6.25%
1,60
-6,65
124.07%

-57,5

EBIT
Million GBP
Released
Forecast
Spread
13,9
12,0
15.98%
-14,5
-12,4
-16.58%
-5,69
-7,06
19.38%
20,8
19,5
6.77%
-30,2
-28,1
-7.4%

-94,9

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
5,01
8,62
-41.81%
-20,9
-18,6
-12.32%
-6,57
-5,94
-10.62%
19,9
21,2
-6.03%
-46,0
-41,5
-10.73%

-95,9

Net income
Million GBP
Released
Forecast
Spread
7,54
9,38
-19.59%
-16,1
-15,9
-0.76%
-6,25
-3,42
-82.6%
19,0
22,1
-13.78%
-39,2
-44,5
12.01%

-89,4

EPS
GBP
Released
Forecast
Spread
0,11
0,14
-19.77%
-0,22
-0,23
1.97%
-0,08
-0,04
-75.9%
0,22
0,23
-2.69%
-0,41
-0,12
-238.19%

-0,91

Announcement Date14/03/1906/05/2015/04/2120/04/2225/04/23-

Quarterly results

Fiscal PeriodDecember 2019 S1 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales
Million GBP
Released
Forecast
Spread
32,1
39,6
-18.85%
32,0
34,5
-7.37%
34,0
37,8
-10.19%
53,7
50,9
5.51%
81,3
67,5
20.31%
61,5
75,4
-18.4%
64,0
61,5
4.19%
76,0
65,8
15.44%
43,1
62,0
-30.52%

47,5

EBITDA
Million GBP
Released
Forecast
Spread
-1,41
13,4
-110.52%
-3,79
-3,50
-8.29%
-0,40
1,60
-124.88%
7,70
2,50
208%
27,1
13,8
96.32%
8,81
9,20
-4.26%
-5,79
2,00
-389.25%
7,39
-0,20
3792.5%
-33,7
-10,7
-216.68%



EBIT
Million GBP
Released
Forecast
Spread
-4,90
8,55
-157.25%
-9,57
-8,10
-18.17%
-5,77
-3,25
-77.42%
0,07
-3,10
102.32%
19,7
5,85
236.03%
1,11
1,80
-38.33%
-19,2
-5,50
-248.31%
-11,1
-18,6
40.52%
-50,7
-30,4
-66.75%

-53,5

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-12,1
4,03
-400.32%
-8,78
-7,20
-21.89%
-6,13
-2,20
-178.45%
-0,45
0,90
-149.56%
19,2
6,40
200.27%
0,66
7,80
-91.5%
-27,4
-9,45
-189.78%
-18,6
-24,9
25.33%
-52,3
-30,6
-71.25%

-51,6

Net income
Million GBP
Released
Forecast
Spread
-10,2
3,25
-412.86%
-5,90
-6,53
9.72%
-6,68
-0,45
-1384.22%
0,43
1,77
-75.43%
18,1
5,57
224.59%
0,94
13,1
-92.81%
-25,5
-10,3
-148.61%
-13,7
-24,4
43.96%
-48,0
-30,9
-55.2%

-48,7

EPS
GBP
Released
Forecast
Spread
-0,15
0,05
-414.86%
-0,07
-0,09
17.55%
-0,09
-0,01
-1398.28%
0,01
0,02
-58.35%
0,21
0,06
229.78%
0,01
0,08
-89.66%
-0,27
-0,11
-146.41%
-0,14
-0,26
45.1%
-0,50
-0,29
-73.59%

-0,49

Announcement Date04/09/1906/05/2017/09/2015/04/2122/09/2120/04/2215/09/2225/04/2320/09/23-